The Advance Wound Care Market is expected to register a CAGR of 3.7% during 2021-2031
Published by mark itwired
Posted on October 4, 2021

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
Published by mark itwired
Posted on October 4, 2021

According to a recent study by Future Market Insights (FMI), the advance wound care market is expected to grow from US$ 10.7 Bn in 2021 to US$ 15.4 Bn by 2031. The market is poised to expand at a CAGR of 3.7% over the forecast period (2021-2031).
Rising prevalence of chronic wounds has created a significant socioeconomic impact. The treatment of chronic wounds requires advance wound care therapies and generally takes long time to heal. The prevalence of diabetic ulcers is rising by 9% annually.
Growing patient pool for diabetic foot ulcer is increasing as compared to the available advance wound care management technologies. Currently, there are more than 4.5 million pressure ulcer patients in the world that require treatment.
More than 9.7 million venous ulcer patients and roughly 10.0 million diabetic ulcer patients require treatment across the world. Annually, over 5 million chronic leg ulcer cases occur in Brazil, while approximately 2.7 million chronic leg ulcer cases occur in Mexico.
Hence, with rising need for advance wound care products for the treatment of various chronic disorders, adoption within hospitals and ambulatory surgical centers is expected to increase. Thereby, bolstering market growth.
Number of pressure and venous ulcer patients has grown from approx. 7% in developed countries, such as the U.S., Germany, and the U.K., which is further expected to drive the growth of the market for advance wound care products.
Focus on collaboration with surgeons for better wound management, improvement and streamlining of regulatory processes and inter and intra-departmental collaboration between surgeons and their support staff for wound management plays a key role in ensuring better wound management and promotes the growth of the advance wound care market.
Request The Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13947
“Increasing prevalence of chronic wounds and growing awareness towards adoption of medical treatment across the globe will propel the market growth over the next ten years,” says the FMI Analyst
Some of the leading manufacturers of advance wound care market are focusing on product launch and expansion strategies for global expansion objectives, thereby, enhancing their market presence.
The key market players covered by FMI include B. Braun Melsungen AG, Mölnlycke Health Care, ConvaTec Group plc, Coloplast A/S, Johnson and Johnson, Medline Industries Inc., 3M, QIAGEN N.V, Essity AB (BSN Medical), Smith and Nephew plc, BOENMED, Hakuzo Medical Asia Co. Ltd.
Speak To Analyst about queries @ https://www.futuremarketinsights.com/ask-question/rep-gb-13947
The global advance wound care market value is expected to grow from US$ 10.7 Bn in 2021 to US$ 15.4 Bn by 2031-end.
The global advance wound care market is projected to expand at CAGR of 3.7% during the forecast period.
From 2016-2020, the advanced wound care market grew at the rate of 3.6% owing to the consistently rising demand for first-aid and versatile products and increasing number of trauma and burn cases.
Sales of advance wound care products is expected to rise as demand for first aid and versatility of products increases. Also, rising elderly population and incidence of diabetic foot ulcers will boost market growth. Further, development, and incorporation of wound-care curriculum, rising prevalence of chronic wounds, reluctance in accepting novel technologies, and high cost of advance wound management products are the key factors propelling growth.
U.S, UK, China, Japan, and Germany are the top 5 countries that are driving the demand for advance wound care products.
Europe holds around 30% revenue share in the overall advance wound care products market in 2021. Germany is expecte to remain the most lucrative market in terms of revenue, acquiring around 25% of Europe’s market share.
The East Asia market is set to exhibit a CAGR of 6.6% during the forecast period on the back of increasing rate of diabetes and improving healthcare expenditure.
The post The Advance Wound Care Market is expected to register a CAGR of 3.7% during 2021-2031 appeared first on Market Research Blog.
According to a recent study by Future Market Insights (FMI), the advance wound care market is expected to grow from US$ 10.7 Bn in 2021 to US$ 15.4 Bn by 2031. The market is poised to expand at a CAGR of 3.7% over the forecast period (2021-2031).
Rising prevalence of chronic wounds has created a significant socioeconomic impact. The treatment of chronic wounds requires advance wound care therapies and generally takes long time to heal. The prevalence of diabetic ulcers is rising by 9% annually.
Growing patient pool for diabetic foot ulcer is increasing as compared to the available advance wound care management technologies. Currently, there are more than 4.5 million pressure ulcer patients in the world that require treatment.
More than 9.7 million venous ulcer patients and roughly 10.0 million diabetic ulcer patients require treatment across the world. Annually, over 5 million chronic leg ulcer cases occur in Brazil, while approximately 2.7 million chronic leg ulcer cases occur in Mexico.
Hence, with rising need for advance wound care products for the treatment of various chronic disorders, adoption within hospitals and ambulatory surgical centers is expected to increase. Thereby, bolstering market growth.
Number of pressure and venous ulcer patients has grown from approx. 7% in developed countries, such as the U.S., Germany, and the U.K., which is further expected to drive the growth of the market for advance wound care products.
Focus on collaboration with surgeons for better wound management, improvement and streamlining of regulatory processes and inter and intra-departmental collaboration between surgeons and their support staff for wound management plays a key role in ensuring better wound management and promotes the growth of the advance wound care market.
Request The Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13947
“Increasing prevalence of chronic wounds and growing awareness towards adoption of medical treatment across the globe will propel the market growth over the next ten years,” says the FMI Analyst
Some of the leading manufacturers of advance wound care market are focusing on product launch and expansion strategies for global expansion objectives, thereby, enhancing their market presence.
The key market players covered by FMI include B. Braun Melsungen AG, Mölnlycke Health Care, ConvaTec Group plc, Coloplast A/S, Johnson and Johnson, Medline Industries Inc., 3M, QIAGEN N.V, Essity AB (BSN Medical), Smith and Nephew plc, BOENMED, Hakuzo Medical Asia Co. Ltd.
Speak To Analyst about queries @ https://www.futuremarketinsights.com/ask-question/rep-gb-13947
The global advance wound care market value is expected to grow from US$ 10.7 Bn in 2021 to US$ 15.4 Bn by 2031-end.
The global advance wound care market is projected to expand at CAGR of 3.7% during the forecast period.
From 2016-2020, the advanced wound care market grew at the rate of 3.6% owing to the consistently rising demand for first-aid and versatile products and increasing number of trauma and burn cases.
Sales of advance wound care products is expected to rise as demand for first aid and versatility of products increases. Also, rising elderly population and incidence of diabetic foot ulcers will boost market growth. Further, development, and incorporation of wound-care curriculum, rising prevalence of chronic wounds, reluctance in accepting novel technologies, and high cost of advance wound management products are the key factors propelling growth.
U.S, UK, China, Japan, and Germany are the top 5 countries that are driving the demand for advance wound care products.
Europe holds around 30% revenue share in the overall advance wound care products market in 2021. Germany is expecte to remain the most lucrative market in terms of revenue, acquiring around 25% of Europe’s market share.
The East Asia market is set to exhibit a CAGR of 6.6% during the forecast period on the back of increasing rate of diabetes and improving healthcare expenditure.
The post The Advance Wound Care Market is expected to register a CAGR of 3.7% during 2021-2031 appeared first on Market Research Blog.